US5466823A
(en)
|
1993-11-30 |
1995-11-14 |
G.D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides
|
US6492411B1
(en)
|
1993-11-30 |
2002-12-10 |
G. D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
|
US6716991B1
(en)
|
1993-11-30 |
2004-04-06 |
G. D. Searle & Co. |
Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation
|
AU3815495A
(en)
*
|
1994-11-08 |
1996-05-31 |
Eisai Co. Ltd. |
Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects
|
US6429221B1
(en)
*
|
1994-12-30 |
2002-08-06 |
Celgene Corporation |
Substituted imides
|
CN1174970C
(zh)
*
|
1995-05-25 |
2004-11-10 |
G·D·瑟尔公司 |
3-卤代烷基-1h-吡唑的制备方法
|
WO1996038418A1
(fr)
|
1995-06-02 |
1996-12-05 |
G.D. Searle & Co. |
Derives heterocyclo-substitues d'acide hydroxamique utilises comme inhibiteurs de la cyclo-oxygenase-2 et de la 5-lipoxygenase
|
US5700816A
(en)
*
|
1995-06-12 |
1997-12-23 |
Isakson; Peter C. |
Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor
|
EP0833664A1
(fr)
*
|
1995-06-12 |
1998-04-08 |
G.D. SEARLE & CO. |
Traitement d'inflammations par une combinaison d'un inhibiteur de la cyclooxygenase-2 et d'un antagoniste du recepteur de leukotriene b 4?
|
CA2224517A1
(fr)
*
|
1995-06-12 |
1996-12-27 |
G.D. Searle & Co. |
Compositions comprenant un inhibiteur de cyclooxygenase-2 et un inhibiteur de 5-lipoxygenase
|
US6593361B2
(en)
|
1995-07-19 |
2003-07-15 |
Merck & Co Inc |
Method of treating colonic adenomas
|
US5968974A
(en)
|
1995-07-19 |
1999-10-19 |
Merck & Co., Inc. |
Method of treating colonic adenomas
|
US5756529A
(en)
*
|
1995-09-29 |
1998-05-26 |
G.D. Searle & Co. |
Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
|
GB9520584D0
(en)
*
|
1995-10-09 |
1995-12-13 |
Fujisawa Pharmaceutical Co |
Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
|
KR19990064310A
(ko)
*
|
1995-10-17 |
1999-07-26 |
윌리암스 로저 에이 |
시클로옥시게나제-2의 검출방법
|
EP0880363B1
(fr)
|
1996-02-13 |
2002-09-11 |
G.D. SEARLE & CO. |
Combinaisons a effets immunosuppresseurs comprenant un inhibiteur de cyclooxygenase-2 et un inhibiteur de la leucotriene a 4 hydrolase
|
DE69709069T2
(de)
|
1996-02-13 |
2002-07-04 |
G.D. Searle & Co., Chicago |
Zusammensetzungen mit immunosuppressiven wirkungen, welche 5-lipoxygenase-inhibitoren und cyclooxygenase-2-inhibitoren enthalten
|
AU2250097A
(en)
|
1996-02-13 |
1997-09-02 |
G.D. Searle & Co. |
Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist
|
US5908858A
(en)
*
|
1996-04-05 |
1999-06-01 |
Sankyo Company, Limited |
1,2-diphenylpyrrole derivatives, their preparation and their therapeutic uses
|
WO1997038986A1
(fr)
|
1996-04-12 |
1997-10-23 |
G.D. Searle & Co. |
Derives benzenesulfonamide substitue utilisables comme precurseurs des inhibiteurs du cox-2
|
US5677318A
(en)
*
|
1996-07-11 |
1997-10-14 |
Merck Frosst Canada, Inc. |
Diphenyl-1,2-3-thiadiazoles as anti-inflammatory agents
|
RU2239429C2
(ru)
*
|
1996-10-15 |
2004-11-10 |
Джи. Ди. Сирл Энд Ко. |
Способ применения ингибиторов циклооксигеназы-2 для лечения и профилактики неоплазии
|
IT1287174B1
(it)
*
|
1996-11-15 |
1998-08-04 |
Angelini Ricerche Spa |
Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
|
EP0941080A2
(fr)
*
|
1996-11-19 |
1999-09-15 |
G.D. SEARLE & CO. |
Procede d'utilisation d'inhibiteurs de cyclo-oxygenase-2 comme agents anti-angiogeniques
|
PT971714E
(pt)
*
|
1997-04-03 |
2002-12-31 |
Searle & Co |
Metodo utilizando inibidores ciclooxigenase-2 no tratamento e prevencao da demencia
|
CA2286673A1
(fr)
*
|
1997-04-18 |
1998-10-29 |
G.D. Searle & Co. |
Procede relatif a l'utilisation d'inhibiteurs de cyclooxygenase-2 dans la prevention des maladies cardiovasculaires
|
US20040072889A1
(en)
*
|
1997-04-21 |
2004-04-15 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia
|
AU750356B2
(en)
*
|
1997-09-24 |
2002-07-18 |
Fujisawa Pharmaceutical Co., Ltd. |
1,5-diphenylpyrazole derivatives
|
AUPO941497A0
(en)
*
|
1997-09-24 |
1997-10-16 |
Fujisawa Pharmaceutical Co., Ltd. |
Novel compounds
|
FR2769311B1
(fr)
*
|
1997-10-07 |
1999-12-24 |
Union Pharma Scient Appl |
Nouveaux derives 3,4-diarylthiazolin-2-one ou -2-thione, leurs procedes de preparation et leurs utilisations en therapeutique
|
US5972986A
(en)
*
|
1997-10-14 |
1999-10-26 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
|
AUPP042397A0
(en)
*
|
1997-11-18 |
1997-12-11 |
Fujisawa Pharmaceutical Co., Ltd. |
5-arylpyrazole compounds
|
US6025353A
(en)
*
|
1997-11-19 |
2000-02-15 |
G.D. Searle & Co. |
Method of using cyclooxygenase-2 inhibitors as anti-angiogenic agents
|
US6887893B1
(en)
|
1997-12-24 |
2005-05-03 |
Sankyo Company, Limited |
Methods and compositions for treatment and prevention of tumors, tumor-related disorders and cachexia
|
CA2327185A1
(fr)
*
|
1998-04-08 |
1999-10-14 |
Abbott Laboratories |
Inhibiteurs de type pyrazole de la production de cytokine
|
US6294558B1
(en)
|
1999-05-31 |
2001-09-25 |
Pfizer Inc. |
Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
|
US6727238B2
(en)
|
1998-06-11 |
2004-04-27 |
Pfizer Inc. |
Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
|
USRE39708E1
(en)
|
1998-08-07 |
2007-06-26 |
Chiron Corporation |
Estrogen receptor modulators
|
EP1126841B1
(fr)
*
|
1998-11-02 |
2004-12-15 |
Merck & Co., Inc. |
Combinaisons d'une agoniste 5ht1b/1d et d'un inhibiteur selective de cox-2 destinees au traitement de migraine
|
SA99191255B1
(ar)
*
|
1998-11-30 |
2006-11-25 |
جي دي سيرل اند كو |
مركبات سيليكوكسيب celecoxib
|
US6649645B1
(en)
*
|
1998-12-23 |
2003-11-18 |
Pharmacia Corporation |
Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
|
US20040122011A1
(en)
*
|
1998-12-23 |
2004-06-24 |
Pharmacia Corporation |
Method of using a COX-2 inhibitor and a TACE inhibitors as a combination therapy
|
US6858598B1
(en)
|
1998-12-23 |
2005-02-22 |
G. D. Searle & Co. |
Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US6833373B1
(en)
|
1998-12-23 |
2004-12-21 |
G.D. Searle & Co. |
Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
|
US20010024664A1
(en)
*
|
1999-03-19 |
2001-09-27 |
Obukowicz Mark G. |
Selective COX-2 inhibition from edible plant extracts
|
AU4308300A
(en)
*
|
1999-05-03 |
2000-11-17 |
Dr. Reddy's Research Foundation |
Pyrazoles having antiinflammatory activity
|
CO5261541A1
(es)
*
|
1999-05-14 |
2003-03-31 |
Pfizer Prod Inc |
Terapia de combinacion para el tratamiento de la migrana
|
EP1178795A1
(fr)
*
|
1999-05-17 |
2002-02-13 |
Ilex Oncology, Inc. |
Utilisation combinee d'eflornithine hydrochloride et de celecoxib pour la chimioprevention et le traitement du cancer
|
CO5190664A1
(es)
|
1999-06-30 |
2002-08-29 |
Pfizer Prod Inc |
Terapia de combinacion para el tratamiento de migrana administracion de un receptor 5ht, cafeina y un inhibidor de ciclooxigenasa-2
|
DE60004001T2
(de)
|
1999-12-03 |
2004-04-15 |
Pfizer Products Inc., Groton |
Acetylenderivate zur Verwendung als schmerzstillendes oder entzündungshemmendes Mittel
|
WO2001040216A1
(fr)
|
1999-12-03 |
2001-06-07 |
Pfizer Products Inc. |
Derive heterocyclo-alkylsulfonyle pyrazole en tant qu'agents anti-inflammatoires/analgesiques
|
ES2208227T3
(es)
|
1999-12-03 |
2004-06-16 |
Pfizer Products Inc. |
Compuestos de heteroarilfenilpirazol como agentes antiinflamatorios/analgesicos.
|
DE60001623T2
(de)
|
1999-12-03 |
2003-12-18 |
Pfizer Products Inc., Groton |
Sulfamoylheteroarylpyrazolverbindungen zur Verwendung als analgetisches/entzündungshemmendes Mittel
|
UA74539C2
(en)
*
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
HUP0200580A3
(en)
*
|
1999-12-08 |
2002-12-28 |
Pharmacia Corp Chicago |
Polymorphic crystalline forms of celecoxib, process their preparation and pharmaceutical compositions containing them
|
HUP0201450A3
(en)
*
|
1999-12-08 |
2003-02-28 |
Pharmacia Corp Chicago |
Solid-state form of celecoxib having enhanced bioavailability, pharmaceutical compositions containing it and their preparation
|
NZ513960A
(en)
*
|
1999-12-08 |
2004-02-27 |
Pharmacia Corp |
Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
|
EP1246621A4
(fr)
|
1999-12-23 |
2004-11-24 |
Nitromed Inc |
Inhibiteurs de cyclooxygenase-2 nitroses et nitrosyles, compositions et procedes d'utilisation
|
CA2400858A1
(fr)
*
|
2000-03-31 |
2001-10-11 |
Shokyo Miki |
Derives heterocycliques fondus, leur production et leur utilisation
|
AU2001253749A1
(en)
*
|
2000-04-25 |
2001-11-07 |
Pharmacia Corporation |
2-fluorobenzenesulfonyl compounds for the treatment of inflammation
|
US6403629B2
(en)
*
|
2000-05-02 |
2002-06-11 |
J.B. Chemical And Pharmaceuticals Limited |
Heterocyclic compounds for therapeutic use
|
MY120279A
(en)
|
2000-05-26 |
2005-09-30 |
Pharmacia Corp |
Use of a celecoxib composition for fast pain relief
|
CN100588395C
(zh)
*
|
2000-06-13 |
2010-02-10 |
Wyeth公司 |
含有环氧化酶-2抑制剂的止痛和抗炎药物
|
TR200001872A3
(tr)
|
2000-06-26 |
2002-01-21 |
Fako Ilaclari A.S |
4-[5-(4-Metilfenil-3-(triflorometil)-1H-pirazol-1-il] benzensulfonamit' in yeni kristal biçimi "Biçim I" ve bu ürünün üretilmesine iliskin yöntem.
|
CA2414674A1
(fr)
*
|
2000-07-13 |
2002-01-24 |
Pharmacia Corporation |
Utilisation d'inhibiteurs de cox-2 pour le traitement et la prevention de troubles oculaires a mediation cox-2
|
PE20020146A1
(es)
*
|
2000-07-13 |
2002-03-31 |
Upjohn Co |
Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
|
ATE366569T1
(de)
|
2000-07-20 |
2007-08-15 |
Lauras As |
Verwendung von cox-2 inhibitoren als immunostimulantien zur behandlung von hiv oder aids
|
US6716829B2
(en)
|
2000-07-27 |
2004-04-06 |
Pharmacia Corporation |
Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
|
GB0021494D0
(en)
*
|
2000-09-01 |
2000-10-18 |
Glaxo Group Ltd |
Chemical comkpounds
|
US20030219461A1
(en)
*
|
2000-09-12 |
2003-11-27 |
Britten Nancy J. |
Parenteral combination therapy for infective conditions
|
JP2004517838A
(ja)
*
|
2000-12-15 |
2004-06-17 |
ファルマシア・コーポレーション |
非食用植物抽出物による選択的cox−2阻害
|
WO2002047706A2
(fr)
*
|
2000-12-15 |
2002-06-20 |
Pharmacia Corporation |
Inhibition sélective de la cox-2 au moyen d'extraits végétaux
|
US7115565B2
(en)
*
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
WO2002062391A2
(fr)
*
|
2001-02-02 |
2002-08-15 |
Pharmacia Corporation |
Methode d'utilisation d'un inhibiteur de la cyclooxygenase-2 et de steroides sexuels dans une polytherapie pour traiter et prevenir la dysmenorrhee
|
ITMI20010733A1
(it)
|
2001-04-05 |
2002-10-05 |
Recordati Chem Pharm |
Uso di inibitori dell'isoenzina cox-2 per il trattamento dell'incontinenza urinaria
|
US20030105144A1
(en)
|
2001-04-17 |
2003-06-05 |
Ping Gao |
Stabilized oral pharmaceutical composition
|
US20030105141A1
(en)
*
|
2001-04-17 |
2003-06-05 |
Ping Gao |
Finely self-emulsifiable pharmaceutical composition
|
US6673818B2
(en)
|
2001-04-20 |
2004-01-06 |
Pharmacia Corporation |
Fluoro-substituted benzenesulfonyl compounds for the treatment of inflammation
|
GB0112810D0
(en)
*
|
2001-05-25 |
2001-07-18 |
Glaxo Group Ltd |
Pyrimidine derivatives
|
GB0112802D0
(en)
*
|
2001-05-25 |
2001-07-18 |
Glaxo Group Ltd |
Pyrimidine derivatives
|
DE10129320A1
(de)
*
|
2001-06-19 |
2003-04-10 |
Norbert Mueller |
Verwendung von COX-2 Inhibitoren zur Behandlung von Schizophrenie, wahnhaften Störungen, affektiven Störungen oder Ticstörungen
|
US20060167074A1
(en)
*
|
2001-06-19 |
2006-07-27 |
Norbert Muller |
Methods and compositions for the treatment of psychiatric disorders
|
EP1273582B1
(fr)
|
2001-07-05 |
2005-06-29 |
Pfizer Products Inc. |
Pyrazoles heterocycliques alkylsulfoniques comme agents anti-inflammatoires/analgésiques
|
DE10135027A1
(de)
*
|
2001-07-18 |
2003-02-06 |
Solvay Pharm Gmbh |
Verwendung Trifluoracetylalkyl-substituierter Phenyl-, Phenol- und Benzoylderivate in der Behandlung und/oder Prophylaxe von Obestias und deren Begleit- und/oder Folgeerkrankungen
|
UA80682C2
(en)
*
|
2001-08-06 |
2007-10-25 |
Pharmacia Corp |
Orally deliverable stabilized oral suspension formulation and process for the incresaing physical stability of thixotropic pharmaceutical composition
|
GB0119477D0
(en)
*
|
2001-08-09 |
2001-10-03 |
Glaxo Group Ltd |
Pyrimidine derivatives
|
US20030100594A1
(en)
*
|
2001-08-10 |
2003-05-29 |
Pharmacia Corporation |
Carbonic anhydrase inhibitor
|
US20040067992A1
(en)
*
|
2001-08-10 |
2004-04-08 |
Pharmacia Corporation |
Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia
|
US20030220376A1
(en)
*
|
2001-08-10 |
2003-11-27 |
Pharmacia Corporation |
Methods for treating carbonic anhydrase mediated disorders
|
WO2003013655A2
(fr)
*
|
2001-08-10 |
2003-02-20 |
Pharmacia Corporation |
Inhibiteur d'anhydrase carbonique
|
US20030114416A1
(en)
*
|
2001-08-14 |
2003-06-19 |
Pharmacia Corporation |
Method and compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate
|
US20050101563A1
(en)
*
|
2001-08-14 |
2005-05-12 |
Pharmacia Corporation |
Method and compositions for the treatment and prevention of pain and inflammation
|
US20030114418A1
(en)
*
|
2001-08-14 |
2003-06-19 |
Pharmacia Corporation |
Method for the treatment and prevention of pain and inflammation with glucosamine and a cyclooxygenase-2 selective inhibitor and compositions therefor
|
AR038957A1
(es)
|
2001-08-15 |
2005-02-02 |
Pharmacia Corp |
Terapia de combinacion para el tratamiento del cancer
|
CA2460942A1
(fr)
*
|
2001-09-19 |
2003-03-27 |
Pharmacia Corporation |
Composes de pyrazolyle substitues destines au traitement de l'inflammation
|
UY27450A1
(es)
*
|
2001-09-24 |
2003-04-30 |
Bayer Corp |
Preparación y uso de derivados de imidazol para el tratamiento de la obesidad
|
GT200200183A
(es)
|
2001-09-28 |
2003-05-23 |
|
Procedimiento para preparar derivados de heterocicloalquilsulfonil pirazol
|
WO2003037336A1
(fr)
|
2001-11-02 |
2003-05-08 |
Pfizer Products Inc. |
Derives de 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile et autres composes utilises en tant qu'inhibiteurs de la cyclooxygenase dans le traitement de l'arthrite, de la neurodegeneration et du cancer du colon
|
DE10162121A1
(de)
*
|
2001-12-12 |
2003-06-18 |
Berolina Drug Dev Ab Svedala |
Deuterierte substituierte Pyrazolyl-Benzolsulfonamide sowie diese Verbindungen enthaltende Arzneimittel
|
US20040126438A1
(en)
*
|
2001-12-13 |
2004-07-01 |
Obukowicz Mark G. |
Selective cox-2 inhibition from plant extracts
|
US20040062823A1
(en)
*
|
2001-12-13 |
2004-04-01 |
Obukowicz Mark G. |
Selective cox-2 inhibition from non-edible plant extracts
|
US20030220374A1
(en)
*
|
2002-01-14 |
2003-11-27 |
Pharmacia Corporation |
Compositions and methods of treatment involving peroxisome proliferator-activated receptor-gamma agonists and cyclooxygenase-2 selective inhibitors
|
US20030212138A1
(en)
*
|
2002-01-14 |
2003-11-13 |
Pharmacia Corporation |
Combinations of peroxisome proliferator-activated receptor-alpha agonists and cyclooxygenase-2 selective inhibitors and therapeutic uses therefor
|
US7790905B2
(en)
*
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
US7927613B2
(en)
*
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
EP1494998A2
(fr)
|
2002-03-01 |
2005-01-12 |
University Of South Florida |
Phases solides multicomposants contentant au moins un principe pharmaceutiquement actif
|
TW562937B
(en)
*
|
2002-03-26 |
2003-11-21 |
Nanya Technology Corp |
Method for fast determining defect type of word line
|
AU2003230836A1
(en)
*
|
2002-04-08 |
2003-10-27 |
The Ohio State University Research Foundation |
Compounds and methods for inducing apoptosis in proliferating cells
|
JP2005532293A
(ja)
*
|
2002-04-18 |
2005-10-27 |
ファルマシア・コーポレーション |
シクロオキシゲナーゼ−2(cox2)阻害剤を用いたパーキンソン病の治療のための単剤療法
|
WO2003088958A2
(fr)
*
|
2002-04-18 |
2003-10-30 |
Pharmacia Corporation |
Therapie combinatoire pour le traitement de la maladie de parkinson a l'aide d'un ou de plusieurs inhibiteurs de cyclooxygenase-2 (cox 2)
|
AU2003220483A1
(en)
*
|
2002-05-09 |
2003-11-11 |
Pharmacia Corporation |
Substituted pyrazolyl compounds for the treatment of inflammation
|
KR20050013553A
(ko)
*
|
2002-05-24 |
2005-02-04 |
파마시아 코포레이션 |
디아릴 피라졸의 합성
|
CA2489984A1
(fr)
|
2002-06-21 |
2003-12-31 |
Transform Pharmaceuticals, Inc. |
Compositions pharmaceutiques a dissolution amelioree
|
AU2003247622A1
(en)
|
2002-06-27 |
2004-01-19 |
Nitromed, Inc. |
Cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
JP2005535642A
(ja)
*
|
2002-06-28 |
2005-11-24 |
ニトロメッド インコーポレーティッド |
オキシムおよび/またはヒドラゾンを含有するニトロソ化および/またはニトロシル化シクロオキシゲナーゼ−2選択的阻害剤、組成物、および使用方法
|
KR100467668B1
(ko)
*
|
2002-08-07 |
2005-01-24 |
씨제이 주식회사 |
1,2,4-트리아졸 유도체, 그 제조방법 및 약제학적 조성물
|
AU2003258630A1
(en)
*
|
2002-08-19 |
2004-03-11 |
Glaxo Group Limited |
Pyrimidine derivatives as selective cox-2 inhibitors
|
GB0221443D0
(en)
|
2002-09-16 |
2002-10-23 |
Glaxo Group Ltd |
Pyridine derivates
|
AU2003267231A1
(en)
*
|
2002-09-20 |
2004-04-08 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
US20040087558A1
(en)
*
|
2002-10-24 |
2004-05-06 |
Zeldis Jerome B. |
Methods of using and compositions comprising selective cytokine inhibitory drugs for treatment, modification and management of pain
|
US20050203142A1
(en)
*
|
2002-10-24 |
2005-09-15 |
Zeldis Jerome B. |
Methods of using and compositions comprising immunomodulatory compounds for treatment, modification and management of pain
|
GB0227443D0
(en)
*
|
2002-11-25 |
2002-12-31 |
Glaxo Group Ltd |
Pyrimidine derivatives
|
WO2004047752A2
(fr)
*
|
2002-11-26 |
2004-06-10 |
Transform Pharmaceuticals, Inc. |
Preparations pharmaceutiques de celecoxib
|
WO2004054560A1
(fr)
|
2002-12-13 |
2004-07-01 |
Warner-Lambert Company Llc |
Ligand alpha-2-delta pour traiter des symptomes des voies urinaires inferieures
|
US20040235925A1
(en)
*
|
2002-12-17 |
2004-11-25 |
Pharmacia Corporation |
Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of duloxetine, venlafaxine or atomoxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
|
US20040204411A1
(en)
*
|
2002-12-17 |
2004-10-14 |
Pharmacia Corporation |
Method for the treatment, prevention, or inhibition of a CNS disorder and/or pain and inflammation using a combination of reboxetine and a cyclooxygenase-2 selective inhibitor and compositions thereof
|
US20080153894A1
(en)
*
|
2002-12-19 |
2008-06-26 |
Pharmacia Corporation |
Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis
|
ES2215474B1
(es)
|
2002-12-24 |
2005-12-16 |
J. URIACH & CIA S.A. |
Nuevos derivados de fosforamida.
|
US8183290B2
(en)
*
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
EP2339328A3
(fr)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Compositions pharmaceutiques cocrystallisees de celecoxib
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
CA2552137A1
(fr)
*
|
2003-01-29 |
2004-08-19 |
Children's Medical Center Corporation |
Prevention des adherences chirurgicales a l'aide d'inhibiteurs selectifs du cox-2
|
US20040220155A1
(en)
*
|
2003-03-28 |
2004-11-04 |
Pharmacia Corporation |
Method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith
|
US20060142368A1
(en)
*
|
2003-04-08 |
2006-06-29 |
Ching-Shih Chen |
Compounds and methods for inducing apoptosis in proliferating cells
|
ATE342722T1
(de)
|
2003-05-07 |
2006-11-15 |
Osteologix As |
Behandlung von knorpel/knochen-erkrankungen mit wasserlöslichen strontiumsalzen
|
AU2004237438B2
(en)
*
|
2003-05-07 |
2011-01-20 |
Osteologix A/S |
Strontium combinations for prophylaxis/treatment of cartilage and/or bone conditions
|
CN1309717C
(zh)
*
|
2003-06-03 |
2007-04-11 |
李小虎 |
4-芳基-5h-噻吩-2-酮衍生物、其制法和用途
|
GB0319037D0
(en)
*
|
2003-08-13 |
2003-09-17 |
Glaxo Group Ltd |
7-Azaindole Derivatives
|
US20050119262A1
(en)
*
|
2003-08-21 |
2005-06-02 |
Pharmacia Corporation |
Method for preventing or treating an optic neuropathy with a cox-2 inhibitor and an intraocular pressure reducing agent
|
US20050107350A1
(en)
*
|
2003-08-22 |
2005-05-19 |
Pharmacia Corporation |
Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith
|
US20050131028A1
(en)
*
|
2003-09-11 |
2005-06-16 |
Pharmacia Corporation |
Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders
|
EP1696907B1
(fr)
*
|
2003-10-03 |
2013-04-17 |
The Ohio State University Research Foundation |
Inhibiteurs de signalisation pdk-1/akt
|
US20060079566A1
(en)
*
|
2003-10-03 |
2006-04-13 |
Ching-Shih Chen |
PDK-1/Akt signaling inhibitors
|
US20060014813A1
(en)
*
|
2003-11-26 |
2006-01-19 |
Patrick Connelly |
Pharmaceutical compounds that regenerate in vivo
|
JPWO2005054181A1
(ja)
|
2003-12-01 |
2007-12-06 |
株式会社リバース・プロテオミクス研究所 |
抗癌剤の新規標的タンパク質および対応する新規抗癌剤(スプナール)
|
US7067159B2
(en)
|
2003-12-05 |
2006-06-27 |
New Chapter, Inc. |
Methods for treating prostate cancer with herbal compositions
|
US7070816B2
(en)
|
2003-12-05 |
2006-07-04 |
New Chapter, Inc. |
Methods for treating prostatic intraepithelial neoplasia with herbal compositions
|
TW200526641A
(en)
*
|
2003-12-26 |
2005-08-16 |
Daiichi Seiyaku Co |
Amidopyrazole derivatives
|
US7927821B2
(en)
*
|
2004-04-12 |
2011-04-19 |
Takeda Pharmaceutical Company Limited |
Methods of screening for compounds which bind G protein-coupled receptors
|
ITMI20041032A1
(it)
|
2004-05-24 |
2004-08-24 |
Neuroscienze S C A R L |
Compositi farmaceutici
|
US8067464B2
(en)
|
2004-10-04 |
2011-11-29 |
Nitromed, Inc. |
Compositions and methods using apocynin compounds and nitric oxide donors
|
BRPI0518062A
(pt)
*
|
2004-10-28 |
2008-10-28 |
Celgene Corp |
uso de um modulador de pde4, ou um sal, solvato, ou estereoisÈmero farmaceuticamente aceitável do mesmo, e, composição farmacêutica
|
EP1833476A1
(fr)
|
2004-11-23 |
2007-09-19 |
PLIVA HRVATSKA d.o.o. |
Composition pharmaceutique de celecoxib a liberation prolongee
|
JP5475235B2
(ja)
|
2005-01-21 |
2014-04-16 |
アステックス・セラピューティクス・リミテッド |
医薬化合物
|
US7521435B2
(en)
|
2005-02-18 |
2009-04-21 |
Pharma Diagnostics, N.V. |
Silicon containing compounds having selective COX-2 inhibitory activity and methods of making and using the same
|
US7923465B2
(en)
|
2005-06-02 |
2011-04-12 |
Glenmark Pharmaceuticals S.A. |
Cannabinoid receptor ligands, pharmaceutical compositions containing them, and process for their preparation
|
EP1928859A1
(fr)
*
|
2005-06-17 |
2008-06-11 |
Carex SA |
Derives de pyrazole utilises comme modulateurs du recepteur cannabinoide
|
KR101363278B1
(ko)
|
2005-06-27 |
2014-02-21 |
엑셀리시스 페이턴트 컴퍼니 엘엘씨 |
이미다졸계 lxr 변조제
|
HUP0500730A2
(en)
|
2005-07-29 |
2007-02-28 |
Richter Gedeon Vegyuszeti Gyar |
1,2-diaryl-heterocyclic compounds, their preparation, pharmaceutical compositions comprising thereof and their use
|
WO2007016677A2
(fr)
|
2005-08-02 |
2007-02-08 |
Nitromed, Inc. |
Composes antimicrobiens promoteurs d'oxyde nitrique, compositions et procedes d'utilisation
|
US7838023B2
(en)
|
2005-11-16 |
2010-11-23 |
Nitromed, Inc. |
Furoxan compounds, compositions and methods of use
|
EP1965774A2
(fr)
*
|
2005-12-30 |
2008-09-10 |
Cogentus Pharmaceuticals, Inc. |
Formulations pharmaceutiques à usage oral contenant des médicaments anti-inflammatoires non stéroïdiens et des inhibiteurs d'acides
|
EP2007705A4
(fr)
|
2006-03-29 |
2011-09-07 |
Nicox Sa |
Prostaglandines amplificatrices d'oxyde nitrique, compositions et méthodes d'utilisation
|
US8128460B2
(en)
*
|
2006-09-14 |
2012-03-06 |
The Material Works, Ltd. |
Method of producing rust inhibitive sheet metal through scale removal with a slurry blasting descaling cell
|
WO2008044045A1
(fr)
|
2006-10-12 |
2008-04-17 |
Astex Therapeutics Limited |
Combinaisons pharmaceutiques
|
EP2073803B1
(fr)
|
2006-10-12 |
2018-09-19 |
Astex Therapeutics Limited |
Combinaisons pharmaceutiques
|
EP2121621B1
(fr)
|
2006-12-08 |
2014-05-07 |
Exelixis Patent Company LLC |
Modulateurs lxr et fxr
|
MX2009006575A
(es)
|
2006-12-22 |
2009-07-02 |
Recordati Ireland Ltd |
Terapia de combinacion de trastornos del tracto urinario inferior con ligandos a2d y farmacos anti-inflamatorios no esteroidales (nsaids).
|
FR2911136B1
(fr)
*
|
2007-01-05 |
2009-02-20 |
Sanofi Aventis Sa |
Derives de n-(4-cyano-1h-pyrazol-3-yl)methylamine substitues leur preparation et leur application en therapeutique.
|
CA2676413A1
(fr)
*
|
2007-01-19 |
2008-07-31 |
Mallinckrodt Inc. |
Ligands de liaison a la cycloxygenase-2 diagnostiques et therapeutiques
|
US8227500B2
(en)
*
|
2007-04-11 |
2012-07-24 |
Kissei Pharmaceutical Co., Ltd. |
5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
|
US8039502B2
(en)
|
2007-07-24 |
2011-10-18 |
The Ohio State University Research Foundation |
Anti-infective agents against intracellular pathogens
|
US20090062364A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched celecoxib
|
US8501778B2
(en)
|
2008-06-20 |
2013-08-06 |
Nhwa Pharma. Corporation |
Aralkyl piperidine derivatives and their uses as antalgic or ataractic agent
|
CA2952692C
(fr)
|
2008-09-22 |
2020-04-28 |
Array Biopharma Inc. |
Composes imidazo[1,2b]pyridazine substitues
|
EP2177215A1
(fr)
|
2008-10-17 |
2010-04-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Co-cristaux de tramadol et NSAID
|
HUE037716T2
(hu)
|
2008-10-22 |
2018-09-28 |
Array Biopharma Inc |
Szubsztituált pirazolo[l,5-a]pirimidin vegyületek mint TRK kináz inhibitorok
|
US8785466B2
(en)
*
|
2008-10-31 |
2014-07-22 |
Loyola University Chicago |
Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom
|
US8686017B2
(en)
*
|
2008-10-31 |
2014-04-01 |
Loyola University Chicago |
Methods of using proteinacious channels to identify pharmaceutical treatments and risks, and treatments resulting therefrom
|
US20120108823A1
(en)
|
2009-04-22 |
2012-05-03 |
The Ohio State University Research Foundation |
Anti-francisella agents
|
WO2010150144A2
(fr)
|
2009-06-25 |
2010-12-29 |
Wockhardt Research Centre |
Composition pharmaceutique à dose réduite de célécoxib
|
AR077468A1
(es)
|
2009-07-09 |
2011-08-31 |
Array Biopharma Inc |
Compuestos de pirazolo (1,5 -a) pirimidina sustituidos como inhibidores de trk- quinasa
|
WO2011050944A1
(fr)
|
2009-10-28 |
2011-05-05 |
Ratiopharm Gmbh |
Formulations contenant du célécoxib
|
WO2011055233A2
(fr)
|
2009-11-03 |
2011-05-12 |
Actavis Group Ptc Ehf |
Procédé amélioré pour préparer un polymorphe de célécoxib
|
EP2560966B1
(fr)
|
2010-03-30 |
2021-01-06 |
Verseon International Corporation |
Composés aromatiques multisubstitués utilisés comme inhibiteurs de la thrombine
|
MY191934A
(en)
|
2010-05-20 |
2022-07-19 |
Array Biopharma Inc |
Macrocyclic compounds as trk kinase inhibitors
|
EP2635274B1
(fr)
*
|
2010-11-01 |
2017-12-06 |
The Ohio State University Research Foundation |
Dérivés de célécoxib anti-staphylocoque
|
CN102746231A
(zh)
*
|
2011-04-20 |
2012-10-24 |
天津药物研究院 |
塞来昔布制备工艺
|
AR086745A1
(es)
|
2011-06-27 |
2014-01-22 |
Parion Sciences Inc |
3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
|
ME02651B
(fr)
|
2012-06-13 |
2017-06-20 |
Incyte Holdings Corp |
Composés tricycliques substitués utilisés comme inhibiteurs de fgfr
|
WO2013187965A1
(fr)
|
2012-06-14 |
2013-12-19 |
Mayo Foundation For Medical Education And Research |
Dérivés de pyrazole en tant qu'inhibiteurs de stat3
|
CN102746232A
(zh)
*
|
2012-07-03 |
2012-10-24 |
石药集团中诺药业(石家庄)有限公司 |
一种塞来昔布杂质的制备方法
|
US8859781B2
(en)
|
2012-07-12 |
2014-10-14 |
Euclises Pharmaceuticals, Inc. |
No-releasing nonoate(nitrogen-bound)sulfonamide-linked-coxib anti-cancer agents
|
US9044464B2
(en)
|
2012-07-12 |
2015-06-02 |
Euclises Pharmaceuticals, Inc. |
No-releasing guanidine-coxib anti-cancer agents
|
US9505765B2
(en)
|
2012-07-26 |
2016-11-29 |
Confluence Life Sciences Inc. |
4-alkoxy/aralkoxy-5-substituted-pyrrolopyrimidine compounds as TAK1 inhibitors in disease treatment
|
RU2650402C2
(ru)
|
2012-12-28 |
2018-04-11 |
ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи |
Синергические фунгицидные смеси для борьбы с грибковыми болезнями злаков
|
US9107947B2
(en)
|
2013-01-31 |
2015-08-18 |
The Penn State Research Foundation |
Anti-cancer compositions and methods
|
WO2014138616A2
(fr)
*
|
2013-03-08 |
2014-09-12 |
Translational Drug Development, Llc |
Composés pyrazoles et leurs procédés d'utilisation
|
CA3051327A1
(fr)
|
2013-03-15 |
2014-09-18 |
Verseon Corporation |
Composes aromatiques multisubstitues en tant qu'inhibiteurs de serine protease
|
US9951025B2
(en)
*
|
2013-03-15 |
2018-04-24 |
Verseon Corporation |
Halogenopyrazoles as inhibitors of thrombin
|
CA2909207C
(fr)
|
2013-04-19 |
2021-11-02 |
Incyte Corporation |
Heterocycles bicycliques utilises en tant qu'inhibiteurs de fgfr
|
US9453002B2
(en)
|
2013-08-16 |
2016-09-27 |
Janssen Pharmaceutica Nv |
Substituted imidazoles as N-type calcium channel blockers
|
CN104974091B
(zh)
*
|
2014-04-10 |
2018-01-02 |
沈阳药科大学 |
3‑甲基‑1,5‑二芳基吡唑类化合物及其制备方法和用途
|
RU2017112739A
(ru)
|
2014-09-17 |
2018-10-17 |
Версеон Корпорейшн |
Пиразолил-замещенные пиридоновые соединения как ингибиторы сериновых протеаз
|
SI3699181T1
(sl)
|
2014-11-16 |
2023-06-30 |
Array Biopharma, Inc. |
Kristalinična oblika(s)-n-(5-((r)-2-(2,5-difluorofenil)- pirolidin-1-il)-pirazolo(1,5-a)pirimidin-3-il)-3-hidroksipirolidin-1 -karboksamid hidrogen sulfata
|
RU2686987C2
(ru)
|
2014-12-30 |
2019-05-06 |
ДАУ АГРОСАЙЕНСИЗ ЭлЭлСи |
Пиколинамиды в качестве фунгицидов
|
KR20170100550A
(ko)
|
2014-12-30 |
2017-09-04 |
다우 아그로사이언시즈 엘엘씨 |
살진균 활성을 갖는 피콜린아미드 화합물
|
CA2972034A1
(fr)
|
2014-12-30 |
2016-07-07 |
Dow Agrosciences Llc |
Picolinamides presentant une activite fongicide
|
JP6684810B2
(ja)
|
2014-12-30 |
2020-04-22 |
ダウ アグロサイエンシィズ エルエルシー |
殺真菌剤としてのピコリンアミド化合物の使用
|
US10188109B2
(en)
|
2014-12-30 |
2019-01-29 |
Dow Agrosciences Llc |
Picolinamide compounds with fungicidal activity
|
KR20170103838A
(ko)
|
2015-01-23 |
2017-09-13 |
컨플루언스 라이프 사이언시스, 인코포레이티드 |
염증 및 암의 치료를 위한 헤테로시클릭 itk 저해제
|
CR20170390A
(es)
|
2015-02-20 |
2017-10-23 |
Incyte Holdings Corp |
Heterociclos biciclicos como inhibidores de fgfr
|
MA41551A
(fr)
|
2015-02-20 |
2017-12-26 |
Incyte Corp |
Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
|
HRP20221287T1
(hr)
|
2015-02-27 |
2023-02-03 |
Verseon International Corporation |
Supstituirani pirazolni spojevi kao inhibitori serin proteaze
|
WO2016177776A1
(fr)
|
2015-05-04 |
2016-11-10 |
Academisch Medisch Centrum |
Biomarqueurs pour la détection de l'insensibilité à l'aspirine
|
AU2016267685A1
(en)
|
2015-05-28 |
2017-12-07 |
Dr. Reddy's Laboratories Ltd. |
Oral composition of celecoxib for treatment of pain
|
CN104945388A
(zh)
*
|
2015-07-09 |
2015-09-30 |
南京大学 |
4-(3-(3-(4-氯香豆素)-酰腙)-5-苯基-吡唑)苯磺酰胺类衍生物的制备方法及在抗癌药物中的应用
|
TN2018000138A1
(en)
|
2015-10-26 |
2019-10-04 |
Array Biopharma Inc |
Point mutations in trk inhibitor-resistant cancer and methods relating to the same
|
US20190038756A1
(en)
|
2016-02-10 |
2019-02-07 |
Cocoon Biotech Inc. |
Compositions including benzenesulfonamide-containing non-steroidal anti-inflammatory drugs, silk fibroin, and a gelling agent and uses thereof
|
US10045991B2
(en)
|
2016-04-04 |
2018-08-14 |
Loxo Oncology, Inc. |
Methods of treating pediatric cancers
|
TN2018000335A1
(en)
|
2016-04-04 |
2020-01-16 |
Loxo Oncology Inc |
Liquid formulations of (s)-n-(5-((r)-2-(2,5-difluorophenyl)-pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide
|
ES2952056T3
(es)
|
2016-05-18 |
2023-10-26 |
Loxo Oncology Inc |
Preparación de (s)-n-(5-((r)-2-(2,5-difluorofenil)pirrolidin-1-il)pirazolo[1,5-a]pirimidin-3-il)-3-hidroxipirrolidina-1-carboxamida
|
BR112018074486A2
(pt)
|
2016-05-27 |
2019-05-28 |
Dr Reddy´S Laboratories Ltd |
composição oral de celecoxib para tratamento da dor
|
JOP20190092A1
(ar)
|
2016-10-26 |
2019-04-25 |
Array Biopharma Inc |
عملية لتحضير مركبات بيرازولو[1، 5-a]بيريميدين وأملاح منها
|
JOP20190213A1
(ar)
|
2017-03-16 |
2019-09-16 |
Array Biopharma Inc |
مركبات حلقية ضخمة كمثبطات لكيناز ros1
|
TWI774761B
(zh)
|
2017-05-02 |
2022-08-21 |
美商科迪華農業科技有限責任公司 |
用於穀物中的真菌防治之協同性混合物
|
WO2018204438A1
(fr)
|
2017-05-02 |
2018-11-08 |
Dow Agrosciences Llc |
Utilisation d'un composé picolinamide acyclique en tant que fongicide pour lutter contre des maladies fongiques sur des gazons
|
TW201842851A
(zh)
|
2017-05-02 |
2018-12-16 |
美商陶氏農業科學公司 |
用於穀類中的真菌防治之協同性混合物
|
AR111960A1
(es)
|
2017-05-26 |
2019-09-04 |
Incyte Corp |
Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
|
AU2018360059B2
(en)
|
2017-11-03 |
2023-07-13 |
Aclaris Therapeutics, Inc. |
Substituted pyrrolopyrimidine JAK inhibitors and methods of making and using the same
|
BR102019004480B1
(pt)
|
2018-03-08 |
2023-03-28 |
Dow Agrosciences Llc |
Picolinamidas como fungicidas
|
WO2019213544A2
(fr)
|
2018-05-04 |
2019-11-07 |
Incyte Corporation |
Formes solides d'un inhibiteur de fgfr et leurs procédés de préparation
|
BR112020022373A2
(pt)
|
2018-05-04 |
2021-02-02 |
Incyte Corporation |
sais de um inibidor de fgfr
|
CA3109192A1
(fr)
|
2018-08-10 |
2020-02-13 |
Aclaris Therapeutics, Inc. |
Inhibiteurs de pyrrolopyrimidine itk
|
CN111039982A
(zh)
*
|
2018-10-12 |
2020-04-21 |
南京大学 |
一类含新型磷脂胺骨架的吡唑磺胺衍生物的设计、合成
|
KR20210076072A
(ko)
|
2018-10-15 |
2021-06-23 |
코르테바 애그리사이언스 엘엘씨 |
옥시피콜린아미드의 합성 방법
|
WO2020185532A1
(fr)
|
2019-03-08 |
2020-09-17 |
Incyte Corporation |
Méthodes de traitement du cancer au moyen d'un inhibiteur de fgfr
|
SG11202108927UA
(en)
|
2019-05-02 |
2021-09-29 |
Aclaris Therapeutics Inc |
Substituted pyrrolopyridines as jak inhibitors
|
US11591329B2
(en)
|
2019-07-09 |
2023-02-28 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
JOP20220083A1
(ar)
|
2019-10-14 |
2023-01-30 |
Incyte Corp |
حلقات غير متجانسة ثنائية الحلقة كمثبطات لـ fgfr
|
US11566028B2
(en)
|
2019-10-16 |
2023-01-31 |
Incyte Corporation |
Bicyclic heterocycles as FGFR inhibitors
|
BR112022010664A2
(pt)
|
2019-12-04 |
2022-08-16 |
Incyte Corp |
Derivados de um inibidor de fgfr
|
JP2023505258A
(ja)
|
2019-12-04 |
2023-02-08 |
インサイト・コーポレイション |
Fgfr阻害剤としての三環式複素環
|
WO2021146424A1
(fr)
|
2020-01-15 |
2021-07-22 |
Incyte Corporation |
Hétérocycles bicycliques en tant qu'inhibiteurs de fgfr
|
US20240066069A1
(en)
|
2021-01-08 |
2024-02-29 |
Seoul National University R&Db Foundation |
Dried cell secretome-based therapeutic agent for osteoarthritis treatment
|
TW202313611A
(zh)
|
2021-06-09 |
2023-04-01 |
美商英塞特公司 |
作為fgfr抑制劑之三環雜環
|
CN114292235B
(zh)
*
|
2021-12-29 |
2023-04-14 |
江苏天和制药有限公司 |
一种地拉考昔的制备和提纯方法
|